AI & ChatGPT searches , social queries for TRABECTEDIN
Search references for TRABECTEDIN. Phrases containing TRABECTEDIN
See searches and references containing TRABECTEDIN!
Search references for TRABECTEDIN. Phrases containing TRABECTEDIN
See searches and references containing TRABECTEDIN!TRABECTEDIN
Chemical compound
Trabectedin, sold under the brand name Yondelis, is an antitumor chemotherapy medication for the treatment of advanced soft-tissue sarcoma and ovarian
Trabectedin
Cancer originating in smooth muscle
doxorubicin/ifosfamide and doxorubicin combination/gemcitabine and docetaxel/trabectedin; pazopanib is the targeted therapy used in metastatic leiomyosarcoma
Leiomyosarcoma
Tumor originating in adipose (fat) tissue
and/or trabectedin have been found useful: a phase III clinical trial showed progression-free survival times in MLS patients treated with trabectedin or dacarbazine
Liposarcoma
Biological kingdom
discovery in the 18th century. Some medicines such as the cancer drug trabectedin are based on toxins or other molecules of animal origin. People have
Animal
Species of sea squirt
described to science in 1880 by William Abbott Herdman. The cancer drug trabectedin can be isolated from this species. Ecteinascidia turbinata is a colonial
Ecteinascidia_turbinata
Chemical compound
Lurbinectedin is structurally similar to trabectedin, although the tetrahydroisoquinoline present in trabectedin is replaced with a tetrahydro β-carboline
Lurbinectedin
V | W | X | Y | Z Ta–Td | Te | Tf–Th | Ti | Tj–Tq | Tra–Tri | Trj–Tz trabectedin (USAN) trabedersen (USAN) traboxopine (INN) tracazolate (INN) Tracleer
List_of_drugs:_Tr–Tri
Spanish pharmaceutical company
obtain the first drug against cancer developed entirely in Spain, the trabectedin (ecteinascidin 743 or ET-743). This chemical compound began to be marketed
PharmaMar
Medical condition
left axillary region of 40 year old man. Horizontal section. Lipoma Trabectedin "Orphanet: Myxoid/round cell liposarcoma". Orpha.net. Retrieved October
Myxoid_liposarcoma
Medication
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Tretinoin
Chemotherapy and immunosuppressant medication
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Methotrexate
Marine animals, subphylum of chordates
January 2021 undergoing Phase III trials as a treatment for COVID-19 Trabectedin, an FDA approved anticancer drug. Tunicates are able to correct their
Tunicate
Chemotherapy medication
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Doxorubicin
Digestive and Kidney Diseases, 2012, PMID 31643502, retrieved 2024-04-11 "Trabectedin", LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
List_of_antineoplastic_agents
Nonsteroidal anti-inflammatory medication
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Celecoxib
Chemical compound and pharmaceutical drug
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Cisplatin
Medication used as chemotherapy and to suppress the immune system
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Cyclophosphamide
Chemotherapy medication
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Fluorouracil
Pharmaceutical drug classification
L01CE02 Irinotecan L01CE03 Etirinotecan pegol L01CE04 Belotecan L01CX01 Trabectedin L01DA01 Dactinomycin L01DB01 Doxorubicin L01DB02 Daunorubicin L01DB03
ATC_code_L01
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Talazoparib
Concept in pharmacology and biochemistry
doxorubicin and trabectedin can both produce anticancer effect. Doxorubicin is a DNA intercalator that prefers to bind to AT regions, while trabectedin forms guanine
Additive_effect
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Eflornithine
Chemotherapy medication
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Docetaxel
Chemotherapy medication
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Etoposide
Medication
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Venetoclax
National Cancer Institute’s Biological Evaluation Committee in 2011. Trabectedin, aplidine, didemnin, were isolated from sea squirts. Monomethyl auristatin
Sponge_isolates
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Sotorasib
Artificial stimulation of the immune system to treat cancer
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Cancer_immunotherapy
Industrial chemical and medication
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Arsenic_trioxide
Gene therapy medication
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Nadofaragene_firadenovec
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Pemetrexed
Medication used to treat cancer
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Carboplatin
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Vepdegestrant
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Gemcitabine
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Dactolisib
Anticancer drug
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Olutasidenib
Chemical compound; chemotherapy medication
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Vincristine
Chemical compound or substance produced by a living organism, found in nature
S2CID 25117225. Petek BJ, Loggers ET, Pollack SM, Jones RL (February 2015). "Trabectedin in soft tissue sarcomas". Marine Drugs. 13 (2): 974–983. doi:10.3390/md13020974
Natural_product
Medication used for cancer
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Paclitaxel
American gynecologic oncologist
advanced ovarian in 2018. He was also the lead author on the trial of trabectedin in recurrent ovarian cancer. In his study regarding cervical cancer,
Bradley_J._Monk
Glycopeptide antibiotic used to treat various cancers
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Bleomycin
Family of chemical compounds
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Nitrogen_mustard
Gene therapy medication
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Talimogene_laherparepvec
Cancer drug
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Protein-bound_paclitaxel
Endogenous non-proteinogenic amino acid
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Aminolevulinic_acid
Cancer medication
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Temozolomide
Gene therapy medication
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Lisocabtagene_maraleucel
Pharmaceutical drug
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Oxaliplatin
Anti-cancer medication
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Vorasidenib
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Darinaparsin
Gene therapy medication
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Idecabtagene_vicleucel
Chemical compound (cancer therapy drug)
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Olaparib
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Capecitabine
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Triplatin_tetranitrate
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Navitoclax
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Stanford_V
Anti-cancer drug
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Selinexor
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Bortezomib
Pharmaceutical drug
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Cladribine
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Dordaviprone
Experimental cancer drug
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Divarasib
Protein found in humans
Mankin H, Hornicek FJ (2009). "ZNF93 increases resistance to ET-743 (Trabectedin; Yondelis) and PM00104 (Zalypsis) in human cancer cell lines". PLOS ONE
Zinc_finger_protein_93
Enzyme used as medication and in food manufacturing
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Asparaginase
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Dactinomycin
Pharmaceutical drug
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Tebentafusp
Drugs that are useful against cancer
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
List of chemotherapeutic agents
List_of_chemotherapeutic_agents
Chemotherapy regimen for colorectal cancer treatment
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
FOLFIRI
Chemotherapy medication
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Vinblastine
Chemical compound (chemotherapy medication)
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Cytarabine
Pharmaceutical drugs
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Alkylating antineoplastic agent
Alkylating_antineoplastic_agent
this alternative even more expensive. For example, ET-743 (INN name trabectedin, brand name Yondelis) can be isolated from the tunicate Ecteinascidia
Marine_pharmacognosy
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Carfilzomib
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Exisulind
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Taxane
Chemotherapeutic agents used to treat cancer
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Platinum-based_antineoplastic
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Mercaptopurine
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Melphalan
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Bendamustine
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Belotecan
Anti-breast cancer medication
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Abemaciclib
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Azacitidine
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Lomustine
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Belzutifan
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Chlormethine
Medication
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Hydroxycarbamide
Chemical that inhibits the use of a metabolite
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Antimetabolite
Lagoon in Tunisia
squirt (a type of tunicate) to produce the anticancer pharmaceutical trabectedin against soft tissue sarcoma and some ovarian cancers. The El Bibane lagoon
Bahiret_el_Bibane
Medication
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Lifileucel
Cancer medication
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Irinotecan
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
High-dose_chemotherapy
Investigational oral small-molecule drug
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Pelabresib
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Eganelisib
Insertion of molecules between DNA
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Intercalation_(biochemistry)
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Nirogacestat
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Plitidepsin
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Camptothecin
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Diflomotecan
Chemical compound
Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin #WHO-EM ‡Withdrawn from market
Prednimustine
Species of flatworm
19 zooids a day. The tunicate produces a secondary metabolite called trabectedin which has been shown to have anti-tumour properties. As it feeds, the
Maritigrella_crozierae
Class of drugs used to treat malignant tumors
alkylate DNA, while other metabolites interfere with purine biosynthesis. Trabectedin (Yondelis) Soft-tissue sarcoma A special alkylating agent that acts on
Antineoplastic
TRABECTEDIN
TRABECTEDIN
TRABECTEDIN
TRABECTEDIN
TRABECTEDIN
TRABECTEDIN
TRABECTEDIN
TRABECTEDIN
TRABECTEDIN